Pariglasgene Brecaparvovec

3 trials 1 recruiting Orphan designation

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

1 Sponsors

5 Countries

Phase III

Phase I/II

Phase III/IV

Phase III: 1 Phase I/II: 1 Phase III/IV: 1

Sponsors using this IMP

Ultragenyx Pharmaceutical Inc. 3

All trials

3 total

GSDIa Disease Monitoring Program Recruiting

2023-510219-20-00 Phase III/IV 5 countries Ultragenyx Pharmaceutical Inc.
An Phase 3 clinical study comparing a vector transferring the gene for Glucose-6-Phosphatase with placebo in adults with Glycogen Storage Di… Ended

2023-508750-25-00 Phase III 5 countries Ultragenyx Pharmaceutical Inc.
A clinical study to learn about the effects of a virus that transfers the gene for Glucose- 6-Phosphatase (G6Pase) in adults with Glycogen S… Ended

2023-504004-29-00 Phase I/II 2 countries Ultragenyx Pharmaceutical Inc.

Showing 1–3 of 3 trials

← All drugs A–Z